Texas Capital Bancshares Stock (NASDAQ: TCBI)

Texas Capital Bancshares (NASDAQ:TCBI) Stock, Quote.Headers.trade-ideas

Texas Capital Bancshares

Texas Capital Bancshares Inc is a secured lender, with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. The company's national lines of business provide specialized lending products to businesses throughout the United States. The bank operates in Texas' main metropolitan areas, like Austin, Dallas, Fort Worth, Houston, and San Antonio.

Wall Street US stocks

Long Ideas

News

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

HNRG

INBX

TCBI

Over $7M Bet On This Health Care Stock? Check Out These 3 Stocks Executives Are Buying

wall street chart shutter2

ADVM

Around $88M Bet On NextDecade? Check Out These 3 Stocks Insiders Are Buying

Stocks Photo by Jirapong Manustrong on Shutterstock

PFBX

$2.5M Bet On Truist Financial? Check Out These 3 Stocks Insiders Are Buying

Texas Capital Bancshares, Inc. - Common Stock

Texas Capital Bancshares Inc

Texas Capital Bancshares, Inc. - Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B

Wedbush analyst David Chiaverini maintains Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) with a Neutral and raises the price target from $70 to $77.

Price Target

Analyst Ratings

Wedbush Maintains Neutral on Texas Capital Bancshares, Raises Price Target to $77

Truist Securities analyst Brandon King maintains Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) with a Hold and raises the price target from $70 to $80.

Truist Securities Maintains Hold on Texas Capital Bancshares, Raises Price Target to $80

Raymond James analyst Michael Rose upgrades Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) from Market Perform to Outperform and announces $78 price target.

Upgrades

Raymond James Upgrades Texas Capital Bancshares to Outperform, Announces $78 Price Target

DA Davidson analyst Gary Tenner maintains Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) with a Neutral and raises the price target from $65 to $74.

DA Davidson Maintains Neutral on Texas Capital Bancshares, Raises Price Target to $74

JP Morgan analyst Anthony Elian maintains Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) with a Underweight and raises the price target from $70 to $73.

JP Morgan Maintains Underweight on Texas Capital Bancshares, Raises Price Target to $73

Keefe, Bruyette &amp; Woods analyst Wood Lay maintains Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) with a Outperform and maintains $74 price target.

Keefe, Bruyette & Woods Maintains Outperform on Texas Capital Bancshares, Maintains $74 Price Target

Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) in the last three months.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $68.12, along with a high estimate of $77.00 and a low estimate of $60.00. Witnessing a positive shift, the current average has risen by 9.36% from the previous average price target of $62.29.
<img src="https://www.benzinga.com/files/images/story/2024/1725883265_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Texas Capital Bancshares. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brandon Berman</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$77.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Steven Alexopoulos</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$70.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$70.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Ben Gerlinger</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Sell</td>
<td>$60.00</td>
<td>-</td>
</tr>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Matt Olney</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Overweight</td>
<td>$75.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$62.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Casey Haire</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$61.00</td>
<td>$64.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Texas Capital Bancshares. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Texas Capital Bancshares compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Texas Capital Bancshares's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Texas Capital Bancshares's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TCBI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Texas Capital Bancshares analyst ratings.</a>
<h2>All You Need to Know About Texas Capital Bancshares</h2>
Texas Capital Bancshares Inc is a secured lender, with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. The company's national lines of business provide specialized lending products to businesses throughout the United States. The bank operates in Texas' main metropolitan areas, like Austin, Dallas, Fort Worth, Houston, and San Antonio.
<h3>Key Indicators: Texas Capital Bancshares's Financial Health</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Decline in Revenue: Over the 3 months period, Texas Capital Bancshares faced challenges, resulting in a decline of approximately -3.96% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Texas Capital Bancshares's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 13.99%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Texas Capital Bancshares's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 1.3%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Texas Capital Bancshares's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.13%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.81, caution is advised due to increased financial risk.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Texas Capital Bancshares In The Eyes Of 8 Experts

Texas Capital Bancshares, Inc., the parent company of Texas Capital, led by President &amp; CEO, Rob C. Holmes, today announced a series of actions that materially progresses the firm towards realization of the performance targets outlined in its strategic plan, communicated on <a href="https://www.globenewswire.com/Tracker?data=jNritlw69QZMct4nrqUqhM9i8dLnWcs9dOiPmj9J-lCNkIV1MljzAjLNVOR1vUrplV-4ffsgo3ihzlqZrhg__FouHgypDEcVPclUmV3vZmW0C9CbX5Q79-PVeg9CfEUR6lmG0aE5E1jtBmNAagDv6HS0O2dYlZYsEkhy66benwpOSKv0VqAr4GzOGwYsqUKuSYVD5Nh9c0aVPSgvjKDOJXa6jvE690RT_O7L25R-04N5JdqHExxoWvrmqdNumC1K">September 1, 2021</a>. &nbsp;
"Three years after announcing our strategic plan, we are pleased with the tremendous progress made building a balance sheet and a business model worthy of serving the best clients in our markets," said Rob C. Holmes. "Actions announced today represent another deliberate step in translating observed strategic success into targeted financial performance associated with long-term value creation. We remain focused on delivering exceptional results for clients and shareholders by leveraging our differentiated platform."
Strategic Acquisition in Focus Area
Following the multi-year coverage and capability build in its corporate banking healthcare vertical, Texas Capital has entered into an agreement to acquire a portfolio of approximately $400 million in committed exposure to companies in the healthcare sector. Many of the companies in the portfolio are supported by sector-focused sponsors with notable track records of value creation and with whom Texas Capital has significant institutional knowledge. The firm expects these clients to benefit from an extensive solutions-focused platform, with revenue cycle management, healthcare asset-based lending and other sector-specific products integrated with differentiated cash management, commercial banking and investment banking capabilities. The transaction is expected to close this month, subject to customary closing conditions.
Balance Sheet Repositioning
In addition to deliberate investments to expand the portfolio and enhance client-facing services, in August of 2024 the firm continued its multi-year process of effectively rationalizing its legacy balance sheet, selling approximately $1.24 billion of available-for-sale securities with an average book yield of 1.23%, purchased prior to 2021. Cash proceeds from the sale were used to purchase $1.06 billion of securities at a yield of 5.26%, which is expected to contribute an incremental $35 to $40 million in net interest income on an annualized basis based on the federal funds futures curve. The $139 million after tax loss generated by the repositioning, which had no impact on GAAP equity or on Texas Capital's industry leading tangible common equity to tangible assets ratio, is expected to result in a net loss for the third quarter of 2024 before notably improving forward profitability metrics in the fourth quarter of 2024 and subsequent reporting periods.
Structural Operating Model Enhancements
The firm continues to leverage proven capabilities to deliver tech-enabled process improvements that enhance client journeys, reduce risk and deliver structural efficiencies. Action taken in the quarter is expected to reduce anticipated 2025 non-interest expense by approximately $30 million, keeping total non-interest expense nearly flat from adjusted full year 2024. This reduction in non-interest expense is the direct result of material investments made over the previous three years that continue to realign the expense base to support near-term financial performance while also enabling sustained investment to drive long-term strategic objectives.
Expanded Products and Capabilities to Further Serve Clients
Texas Capital Securities Energy Equity Research – To expand Texas Capital Securities' ability to serve its Corporate &amp; Investment Banking clients in the energy industry and adjacent sectors, Texas Capital today announced the hiring of a research and equity specialty sales team led by Derrick Whitfield and Thomas McGarrity. Energy Equity Research is intended to enhance the firm's transaction capabilities, investment insights and dedicated coverage of the energy sector, while also providing a platform to further expand its Institutional Services businesses. Texas Capital Securities Energy Equity Research is expected to publish initiation reports on an initial coverage universe no later than early 2025.
Texas Capital Direct Lending – In August 2024, Texas Capital announced the launch of its Direct Lending platform led by Tim Laczkowski. <a href="https://www.globenewswire.com/Tracker?data=2aPnN0dD-QT-AgNrjV8d4jXD4Ig3gjwxa9U4DkbNbwLZlD54vbaKAZocpYPz-GhyrxZPAPXkTuxcPirLnMT2kBhtQb_7QdZ-b5TVOrKMxmXM7mPkiEdyjRIUxgY5LnZkG3lG4oNKMtxlDoxRA5cmLTqqQvhdI772--rZDubDweacMkcxCUH30R5U-dU0glzvw3625SwWzZIAmdm_MxMrcA==">Texas Capital Direct Lending</a> (TCDL) is focused on providing non-bank term loans to middle market companies, enabling Texas Capital clients and prospects to access a wider array of capital alternatives while enjoying the benefits of Texas Capital's full suite of commercial and investment banking products. The launch of TCDL further extends Texas Capital's ability to provide comprehensive solutions and solidifies the firm's position as the "first call" for middle market companies headquartered in Texas and beyond.
Texas Capital Public Finance – In May 2024, Texas Capital announced the formation of <a href="https://www.globenewswire.com/Tracker?data=2aPnN0dD-QT-AgNrjV8d4pEXeIu41v-b55VrzqA9iNtmtMmSNfh1YpTazQsePygolRG5zR8-XxCK-9AA-dk2tGYEbBFQE1Dv5kk8g88q2-o6azHe_M4wKwGuct6DArwMDrh1oq6CHPboTpbi5beamhYYLEQavU9S4YDJM7OCE3xfs_czhioguo0uAKGkmMU29DBuilejHvBTDhLiEtHHedhXKEpjbbhR2B5-7LHe9Ms9_NmBS6Q-bxeAVVRqyXtryNFgDJBbpYC3CxemKCPwqw==">Texas Capital Securities' Public Finance</a> team to provide municipal underwriting services to governments, nonprofits and institutions in the state of Texas and across the country. Led by industry veteran Steven Genyk, the team now includes dedicated bankers located in Dallas, Houston and Austin aligned against the significant opportunity to serve these important constituents.
Texas Capital SBA Lending – The firm remains committed to serving businesses through the entirety of their lifecycles, with expansion of tailored services for Business Banking clients designed to accelerate client acquisition moving into next year. Leveraging improved coverage and delivery, Texas Capital expects to be a top five SBA lender each year to Texas-based businesses by 2025.
The Texas Capital Transformation
Over the past three years, Texas Capital has undergone an enterprise-wide transformation to become the premier full-service financial services firm, headquartered in Texas, equipped to provide clients with a wide range of differentiated and relevant products and services. Several notable achievements include:
<ul>
<li>Delivered Peer-Leading Balance Sheet Strength – Dedicated to the principle of financial resilience through market and rate cycles, the firm's disciplined balance sheet repositioning throughout the transformation resulted in both a 357 bps increase in total regulatory capital since year-end 2020, and sector-leading capital levels when measured against the largest U.S. banks1.</li>
<li>Launched Texas Capital Securities – The investment bank, founded in 2021, now complements the firm's commercial banking competency by delivering a complete set of solutions to clients within Texas Capital's defined areas of geographic and industry coverage. From its opening in December 2021, the firm has completed over $135 billion in securities trading volume, delivered the largest sole arranged institutional term loans in the country in both 2023 and 20242 and built a broad business capable of delivering advisory, capital markets and other financial solutions. Texas Capital expects to achieve its published target of 10% of total revenue in full-year 2024, a year earlier than the target initially set in 2021.</li>
<li>Best-in-Class Treasury Solutions Platform – The firm's significant multi-year investment to make industry-leading cash management capabilities available to clients continues to result in peer-leading growth in primary operating relationships, revenue and client deposits. Through the second quarter of 2024, treasury product fees as a percentage of revenue has more than doubled from full-year 2020, which, when coupled with top quartile growth in client deposits3, signifies material progress leveraging a best-in-class product and service offerings to effectively satisfy clients' deposit and cash management needs. &nbsp;</li>
</ul>
1) Tangible Common Equity as a percent of Tangible Assets compared to large U.S. financial services firms, which includes G-SIBs (U.S. globally systematically important banks; includes JPM, BAC, C and WFC) and Category II, III, and IV banks with total assets greater than $200bn as of Q2 2024. 2) U.S. data for 2023 and 2024, excluding refinancings and repricing transactions, according to PitchBook LCD. 3) Total deposits excluding indexed, brokered, and Mortgage Finance non-interest-bearing deposits.

Texas Capital Bancshares Announces Strategic Acquisitions, Balance Sheet Repositioning, And New Initiatives As Part Of Transformation Plan Aimed At Long-term Value Creation And Enhanced Client Services​

Although U.S. stocks closed mixed on Monday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Hallador Energy</h3>
<ul>
<li>The Trade: Hallador Energy Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNRG#NASDAQ">HNRG</a>) Director Zarrell Gray <a href="https://www.benzinga.com/quote/HNRG/analyst-ratings">acquired a total of 20,000 shares at</a> an average price of $5.70. To acquire these shares, it cost around $114,000.</li>
<li>What's Happening: On Aug. 6, Hallador Energy reported worse-than-expected second-quarter financial results.</li>
<li>What Hallador Energy Does: Hallador Energy Co is a coal mining company with operations in Indiana, USA, and it is part of the electric power generation industry.</li>
</ul>
<h3 class="wp-block-heading">Texas Capital Bancshares</h3>
<ul>
<li>The Trade: Texas Capital Bancshares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) Director Robert W Stallings acquired a total of 28,813 shares at an average price of $20.15. To acquire these shares, it cost around $580,737.</li>
<li>What's Happening: On Aug. 1, Texas Capital named Todd Jordan to serve as Austin Market President and Leader of Austin Middle Market Banking.</li>
<li>What Texas Capital Bancshares Does: Texas Capital Bancshares Inc is a secured lender, with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business.</li>
</ul>
<h3 class="wp-block-heading">Inhibrx Biosciences</h3>
<ul>
<li>The Trade: Inhibrx Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INBX#NASDAQ">INBX</a>) Director Douglas Forsyth <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 75,000 shares</a> at an average price of $13.83. To acquire these shares, it cost around $1.04 million.</li>
<li>What's Happening: On Aug. 13, Inhibrx Biosciences posted second-quarter EPS of $125.48.</li>
<li>What Inhibrx Biosciences Does: Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40551343/wall-streets-most-accurate-analysts-spotlight-on-3-industrials-stocks-delivering-high-dividend-yield">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Industrials Stocks Delivering High-Dividend Yields</a></li>
</ul>

WIIM

ABCB

AROW

BANC

BANR

BBDO

BSRR

CATY

CCNE

CVBF

DCOM

EBTC

EGBN

EWBC

FIBK

FMAO

FRME

FULT

GBCI

HIFS

HTLF

IBTX

INDB

KRNY

MOFG

NBTB

NYCB

PPBI

RBCAA

SBCF

SFBS

SFNC

TRMK

UMBF

WSFS

Shares of banking companies are trading higher amid overall market strength following Fed Chair Powell's comments about the economy and future rate cuts.

CADE

FCNCA

GGAL

HBAN

WTFC

Shares of banking companies are trading lower amid overall market weakness on US economic concerns.

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">NextDecade</h3>
<ul>
<li>The Trade: NextDecade Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXT#NASDAQ">NEXT</a>) 10% owner Hanwha Ocean Co., Ltd <a href="https://www.benzinga.com/quote/NEXT/analyst-ratings">acquired a total of 11,690,909 shares</a> at an average price of $7.50. To acquire these shares, it cost around $87.7 million.</li>
<li>What's Happening: On July 22, NextDecade named Tarik Skeik as Chief Operating Officer.</li>
<li>What NextDecade Does: NextDecade Corp is a energy company predominantly engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions.</li>
</ul>
<h3 class="wp-block-heading">Adverum Biotechnologies</h3>
<ul>
<li>The Trade: Adverum Biotechnologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADVM#NASDAQ">ADVM</a>) 10% owner Braden Michael Leonard acquired a total of 85,800 shares at an average price of $7.15. To acquire these shares, it cost around $613,470..</li>
<li>What's Happening: On Aug. 1, Adverum Biotechnologies announced FDA Regenerative Medicine Advanced Therapy (RMAT) designation granted for Ixo-vec for the treatment of Wet AMD.</li>
<li>What Adverum Biotechnologies Does: Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company.</li>
</ul>
<h3 class="wp-block-heading">Texas Capital Bancshares</h3>
<ul>
<li>The Trade: Texas Capital Bancshares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) Director Robert W Stallings <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 20,000 shares</a> at an average price of $20.47. To acquire these shares, it cost around $409,300.</li>
<li>What's Happening: On July 18, Texas Capital Bancshares reported worse-than-expected second-quarter financial results.</li>
<li>What Texas Capital Bancshares Does: Texas Capital Bancshares Inc is a secured lender, with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40092849/western-digital-udemy-teladoc-health-and-other-big-stocks-moving-lower-in-thursdays-pre-market-sessi">Western Digital, Udemy, Teladoc Health And Other Big Stocks Moving Lower In Thursday&#8217;s Pre-Market Session</a></li>
</ul>

Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Truist Financial</h3>
<ul>
<li>The Trade: Truist Financial Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) Chairman and CEO William H Rogers Jr <a href="https://www.benzinga.com/quote/TFC/analyst-ratings">acquired a total of 57,300 shares</a> at  an average price of $43.96. To acquire these shares, it cost around $2.52 million.</li>
<li>What's Happening: On July 22, Truist Finl posted upbeat quarterly earnings.</li>
<li>What Truist Financial Does: Based in Charlotte, North Carolina, Truist is the combination of BB&amp;T and SunTrust. Truist is a regional bank with a presence primarily in the Southeastern United States.</li>
</ul>
<h3 class="wp-block-heading">Texas Capital Bancshares</h3>
<ul>
<li>The Trade: Texas Capital Bancshares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) Director Robert W Stallings acquired a total of 5,500 shares at an average price of $20.54. To acquire these shares, it cost around $112,950.</li>
<li>What's Happening: On July 18, Texas Capital Bancshares reported worse-than-expected second-quarter financial results.</li>
<li>What Texas Capital Bancshares Does: Texas Capital Bancshares Inc is a secured lender, with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business.</li>
</ul>
<h3 class="wp-block-heading">Peoples Financial</h3>
<ul>
<li>The Trade: Peoples Financial Corporation (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PFBX#OTC">PFBX</a>) Director Ronald G Barnes <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 1,000 shares</a> at an average price of $16.00. To acquire these shares, it cost around $16,000.</li>
<li>What's Happening: On July 24, the company said net income for the second quarter was $2,329,000 down from $2,910,000 for the year-ago quarter.</li>
<li>What Peoples Financial Does: Peoples Financial Corp is a bank holding company that provides banking, financial and trust services to individuals, small and commercial businesses operating in Mississippi, Louisiana, and Alabama.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39958830/top-3-defensive-stocks-that-are-ticking-portfolio-bombs">Top 3 Defensive Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

JP Morgan analyst Steven Alexopoulos maintains Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) with a Underweight and raises the price target from $63 to $70.

JP Morgan Maintains Underweight on Texas Capital Bancshares, Raises Price Target to $70

Truist Securities analyst Brandon King maintains Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) with a Hold and raises the price target from $62 to $70.

Truist Securities Maintains Hold on Texas Capital Bancshares, Raises Price Target to $70

Citigroup analyst Ben Gerlinger downgrades Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) from Neutral to Sell and announces $60 price target.

Downgrades

Citigroup Downgrades Texas Capital Bancshares to Sell, Announces $60 Price Target

6 analysts have expressed a variety of opinions on Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Texas Capital Bancshares, revealing an average target of $67.17, a high estimate of $75.00, and a low estimate of $61.00. This current average has increased by 0.25% from the previous average price target of $67.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1721401223_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The analysis of recent analyst actions sheds light on the perception of Texas Capital Bancshares by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Matt Olney</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Overweight</td>
<td>$75.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$62.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Casey Haire</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$61.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$61.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Wood Lay</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$74.00</td>
<td>$76.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Texas Capital Bancshares. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Texas Capital Bancshares compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Texas Capital Bancshares's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Texas Capital Bancshares's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/TCBI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Texas Capital Bancshares analyst ratings.</a>
<h2>Unveiling the Story Behind Texas Capital Bancshares</h2>
Texas Capital Bancshares Inc is a secured lender, with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. The company's national lines of business provide specialized lending products to businesses throughout the United States. The bank operates in Texas' main metropolitan areas, like Austin, Dallas, Fort Worth, Houston, and San Antonio.
<h3>Texas Capital Bancshares's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Challenges: Texas Capital Bancshares's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -6.02%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Texas Capital Bancshares's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 8.52%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 0.76%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Texas Capital Bancshares's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.08%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Texas Capital Bancshares's debt-to-equity ratio stands notably higher than the industry average, reaching 0.56. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In-Depth Examination Of 6 Analyst Recommendations For Texas Capital Bancshares

Wedbush analyst David Chiaverini maintains Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) with a Neutral and raises the price target from $62 to $70.

Wedbush Maintains Neutral on Texas Capital Bancshares, Raises Price Target to $70

Stephens &amp; Co. analyst Matt Olney maintains Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) with a Overweight and raises the price target from $73 to $75.

Stephens & Co. Maintains Overweight on Texas Capital Bancshares, Raises Price Target to $75

Shares of Domino&#8217;s Pizza, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) fell sharply during Thursday's session after the company reported <a href="https://www.benzinga.com/news/earnings/24/07/39834307/dominos-pizza-suspends-1-100-global-net-store-outlook-after-q2-earnings-stock-tumbles">mixed quarterly results.</a>
The company reported second-quarter FY24 sales growth of 7.1% year-on-year to $1.097 billion, missing the analyst consensus estimate of $1.103 billion.
The company is temporarily suspending its guidance metric of 1,100+ global net stores growth until the full effect of DPE's store opens and closures on international net store growth are known.
Domino&#8217;s Pizza shares dipped 11.2% to $420.36 on Thursday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Onconetix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCO#NASDAQ">ONCO</a>) climbed 97.6% to $0.2944. On July 15, Onconetix announced closing of warrant exercise for $1.11 million gross proceeds.</li>
<li>Silo Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) jumped 71.6% to $3.86. Silo Pharma said it has entered into a Device and CMC Development Master Plan with Resyca BV, a medical technology provider.</li>
<li>Chuy&#8217;s Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHUY#NASDAQ">CHUY</a>) rose 47.6% to $37.29 after the company and Darden Restaurants, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) jointly announced that Darden will acquire Chuy's Holdings.</li>
<li>JE Cleantech Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JCSE#NASDAQ">JCSE</a>) jumped 24.8% to $0.8873.</li>
<li>CommScope Holding Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COMM#NASDAQ">COMM</a>) gained 19% to $2.0407. Amphenol announced plans to acquire mobile networks businesses from CommScope.</li>
<li>LivePerson, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPSN#NASDAQ">LPSN</a>) gained 18% to $1.1500. LivePerson is expected to release its second quarter financial results after the closing bell on Wednesday, July 31.</li>
<li>Kopin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>) rose 16% to $1.32. Kopin said it has achieved production approval milestone on next generation F-35 OLEDoS Microdisplay.</li>
<li>NKGen Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) surged 15.3% to $1.08 after the company announced it will present new SNK01 biomarker data at the Alzheimer&#8217;s Association International Conference.</li>
<li>ZimVie Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZIMV#NASDAQ">ZIMV</a>) gained 14.7% to $21.74.</li>
<li>Virtu Financial, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRT#NASDAQ">VIRT</a>) rose 13.2% to $26.61 after the company reported better-than-expected second-quarter financial results.</li>
<li>Acurx Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACXP#NASDAQ">ACXP</a>) rose 10.7% to $2.90.</li>
<li>D.R. Horton, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) shares rose 10.6% to $174.29 after the company reported better-than-expected third-quarter financial results and revised its FY24 guidance. Also, the company authorized a new $4 billion share repurchase.</li>
<li>Canadian Solar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) gained 8.3% to $17.89.</li>
<li>Infosys Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFY#NYSE">INFY</a>) rose 7.4% to $22.07 as the company reported first-quarter revenue growth of 2.5% in constant currency terms year-on-year to $4.71 billion, beating the analyst consensus estimate of $4.65 billion.</li>
<li>Ostin Technology Group Co Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) shares climbed 7.1% to $0.2944.</li>
<li>Toll Brothers, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) gained 6% to $135.83 in sympathy with D.R. Horton, which reported better-than-expected third-quarter financial results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Agenus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGEN#NASDAQ">AGEN</a>) shares fell 52.7% to $8.36 after the company announced the FDA discouraged an accelerated approval pathway at the end-of-Phase 2 meeting.</li>
<li>Leslie&#8217;s, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) fell 30.7% to $2.83 after the company reported preliminary financial results for the third quarter and cut its full-year guidance. Multiple analysts also lowered price targets on the stock Thursday morning.</li>
<li>Alaunos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRT#NASDAQ">TCRT</a>) fell 26% to $4.57. Alaunos Therapeutics announced a reverse stock split of 1-for-10, effective July 18.</li>
<li>Aptevo Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) shares fell 23% to $0.4471 after jumping 76% on Wednesday. On July 1, Aptevo Therapeutics announced the closing of $2.75 million offering.</li>
<li>Aditxt, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTX#NASDAQ">ADTX</a>) shares fell 19.7% to $1.86. Aditxt shares climbed around 46% on Wednesday after the company and Evofem amended and restated their merger agreement.</li>
<li>Locafy Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCFY#NASDAQ">LCFY</a>) fell 19% to $5.33.</li>
<li>SunPower Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) fell 17.2% to $2.0850.</li>
<li>Torrid Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) fell 16.7% to $7.16 after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and maintained its $5 price target.</li>
<li>Longeveron Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) declined 16.6% to $3.25. Longeveron announced a $9.0 million registered direct offering priced at-the-market under Nasdaq rules.</li>
<li>Forestar Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOR#NYSE">FOR</a>) fell 13.9% to $30.99 after the company reported worse-than-expected third-quarter EPS and revenues.</li>
<li>Stardust Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) shares declined 13.3% to $21.22 after jumping around 145% on Wednesday.</li>
<li>Cetus Capital Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETU#NASDAQ">CETU</a>) shares declined 13.2% to $8.60 after surging 80% on Wednesday.</li>
<li>Meiwu Technology Company Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WNW#NASDAQ">WNW</a>) fell 13.2% to $1.11 after jumping more than 40% on Wednesday.</li>
<li>Fitell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) fell 12% to $23.55.</li>
<li>American Rebel Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) shares fell 12% to $0.80 after jumping around 32% on Wednesday.</li>
<li>Beyond Meat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>) shares fell 9.4% to $6.49 following a report suggesting the company&#8217;s liquidity has weakened and it is engaging bondholders for debt discussions.</li>
<li>4D Molecular Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDMT#NASDAQ">FDMT</a>) declined 8.1% to $16.73. The company announced the presentation of Phase 2 PRISM interim data.</li>
<li>Texas Capital Bancshares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) fell 6.2% to $66.17 following downbeat quarterly results.</li>
<li>Nokia Oyj (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) fell 5.9% to $3.66 after the company reported mixed quarterly financial results.</li>
<li>Alaska Air Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>) declined 5.4% to $37.85 as the company reported second-quarter 2024 total operating revenue growth of 2% year-over-year to $2.897 billion, missing the consensus of $2.945 billion.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39837919/podcastone-and-2-other-stocks-under-2-insiders-are-buying">PodcastOne And 2 Other Stocks Under $2 Insiders Are Buying</a></li>
</ul>

Intraday Update

Movers

ACXP

ADTX

AGEN

APVO

AREB

BYND

CETU

CHUY

COMM

CSIQ

CURV

FDMT

FTEL

INFY

JCSE

KOPN

LCFY

LESL

LGVN

LPSN

NKGN

ONCO

SDST

SILO

SPWR

TCRT

VIRT

ZIMV

Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

FPF: This High-Yielding CEF Is Taking Steps To Protect Itself Against Banking Problems

An update from Texas Capital Bancshares (TCBI) is now available. Texas Capital Bancshares, Inc. has reaffirmed its commitment to its President and ...

Texas Capital Bancshares Reinforces Executive Compensation Plans

Texas Capital announces launch of Texas Capital Direct Lending platform

Rate-sensitive stocks rise, probe leads to biggest dip in week's financial movers

Warning: TCBI is at high risk of performing badly

Texas Capital Bancshares to acquire ~$400M healthcare portfolio

The latest announcement is out from Texas Capital Bancshares ( ($TCBI) ). Texas Capital Bancshares, Inc. has reported significant strides in its st...

Texas Capital Bancshares Unveils Strategic Growth Initiatives

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Tradeweb Markets (TW – Research Report) and Texas C...

Analysts Offer Insights on Financial Companies: Tradeweb Markets (TW) and Texas Capital Bancshares (TCBI)

Analysts have been eager to weigh in on the Financial sector with new ratings on Texas Capital Bancshares (TCBI – Research Report), Applied Digital...

Analysts Offer Insights on Financial Companies: Texas Capital Bancshares (TCBI), Applied Digital Corporation (APLD) and Allstate (ALL)

Analysts fell to the sidelines weighing in on Newtek Business (NEWT – Research Report), Community Bank System (CBU – Research Report) and Texas Cap...

Analysts Are Neutral on These Financial Stocks: Newtek Business (NEWT), Community Bank System (CBU)

APLD

BACRP

BCDRF

BETR

BNSPF

FITB

FITBI

FITBO

FITBP

FRHC

INGVF

MARA

NEWT

RBCPF

RBMCF

RBSPF

RYBPF

RYLBF

TCBIO

UPST

Press Releases

Federal Home Loan Bank of Dallas and Texas Capital Award $850K for Austin Affordable Housing

General

Texas Capital to Open Full-Service, Digital-Forward Financial Center in Southlake, Texas

Management

Texas Capital Appoints Brett Fenn to Lead Business Banking

Texas Capital Bancshares, Inc. Announces Date for Q2 2024 Operating Results

Earnings

Texas Capital Bancshares, Inc. Announces Second Quarter 2024 Results

Dividends

Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Preferred Stock

Texas Capital Appoints Todd Jordan to Serve as Austin Market President and Leader of Austin Middle Market Banking

Federal Home Loan Bank of Dallas and Texas Capital Award $510K for Veterans Housing

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

Texas Capital Bancshares

Texas Capital Bancshares (TCBI) Forecast

Texas Capital Bancshares (NASDAQ:TCBI) Stock, Quote.Headers.trade-ideas